Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Neuropsychopedagogy positively impacts education quality.

Different drugs are linked to specific mental health issues.

Certain medications can cause serious side effects, so it's important to report them.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Skin diseases can cause psychological issues, and better integration of dermatology and psychiatry is needed to improve patient care.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

Valproic acid and isoniazid can interact, causing toxicity, so careful monitoring is needed.

Seborrheic dermatitis affects quality of life and sleep, linked to stress and nervous system changes.

Many skin patients also have mental health issues, and doctors should treat both together.

Psychoactive drugs can help treat skin conditions linked to psychological issues.

Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.

Finasteride use is linked to increased reports of cognitive problems, especially in younger people with hair loss.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

Some teenagers with anorexia nervosa have worse cognitive abilities, especially in visual and spatial tasks, and this is more common in those with a lower body weight.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Thallium poisoning can cause worsening nerve damage and vision loss without typical symptoms.

Finasteride improved reflexes and motor activity in rats with liver-related brain issues.

Patients with skin diseases rated psychological effects as most impactful, needing a treatment approach that addresses both mind and body.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

MRI can show unusual brain changes in adrenomyeloneuropathy.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Some psychiatric medications can cause reversible hair loss.

Pseudofolliculitis barbae is linked to higher rates of anxiety and depression.

Monitoring for adverse effects in clinical treatments is crucial.

Memantine may slightly improve memory in people with Down syndrome, but more research is needed.

Post-drug syndromes are often overlooked, and better systems and education are needed to improve drug safety.

Psychotropic drugs can interact with natural products, affecting their effectiveness and safety.

Divalproex sodium significantly improved headaches in two-thirds of patients.

Plica neuropathica can be a sign of schizophrenia and improves with antipsychotic treatment.